Australia's most trusted
source of pharma news
Posted 15 January 2025 AM
The opposition has made a scathing assessment of the Federal Government's relationship with stakeholders claiming it holds "borderline contempt" for both pharmaceutical companies and patients.
Responding to a report into the PBS by the Australian National Audit Office (ANAO) released late last year, Shadow Health Minister Senator Anne Ruston said of greatest concern was the revelation the government had failed to conduct an analysis of stakeholder engagement needs or develop an overarching stakeholder engagement plan.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.